Home  Contact
|
|
|
|
|
Emergent
BioSolutions Inc. (NYSE:EBS) announced today that it has submitted a
proposal in response to a request for proposal (RFP) issued by the
U.S. Department of Health and Human Services (HHS) f... |
|
|
|
|
|
|
|
The victims and family members of the 2001 anthrax mailings
have waited patientl... |
|
|
|
|
|
Emergent BioSolutions Inc. announced that it has submitted a
proposal in respons... |
|
|
|
|
|
University of Michigan researchers have recently announced a development in anthrax vaccination. |
|
|
|
|
|
|
|
|
Emergent BioSolutions Incorporated has recently announced plans to deliver 900,000 doses of its anth... |
|
|
|
|
|
Israel has developed an effective Anthrax vaccine through the use of hundreds of volunteer human sub... |
|
|
|
|
|
Israeli researchers have developed their own anthrax vaccine after conducting clandestine experiment... |
|
|
|
|
|
South African health company Intervet International has recently released an anti-anthrax vaccine kn... |
|
|
|
|
|
Researchers in the United States and abroad have developed an oral Salmonella-based vaccine that pro... |
|
|
|
|
|
Coley Pharmaceutical Group, Inc revealed that it has signed a license agreement with Emergent BioSol... |
|
|
|
|
|
The next generation of anthrax vaccines based on protective antigen (rPA), a component of anthrax ex... |
|
|
|
|
|
In a massive restructuring program, American
biopharmaceutical company, VaxGen Inc has said that... |
|
|
|
| | | |
|
|
|
|
|
|
|
|
